Protection of Freedoms Bill

My Lords, I added my name to this amendment because, as noble Lords will know, I have a long-standing interest in promoting the interests of our universities. Like others, I feel that when the Freedom of Information Act was passed, this House did not foresee how its provisions would relate to the university context. The Act’s intention—to increase public access to information held by public authorities—is right. In relation to university research, like others, I strongly support access to research data and the transparency of the research process. That is a culture that the Government should encourage, not least because it will increase public confidence in science and research and will also help the research community to make the most of the products of its collective work. However, access to research information must be balanced with the need to support the research process itself. It is not in the national interest to provide access to information in a way that inhibits research in contentious areas, discourages people taking part in research projects or drives commercial research funders away from the university research base. Nor is it in our national interest to put a brake on the competitive position of our universities internationally. There are already exemptions that can be used by university research staff to refuse to disclose information requested under FOI. The ICO has done much to explain, in sector-specific guidance as the Minister indicated, how the exemptions can be applied by universities, but I do not believe that they go far enough. For example, although there is an exemption for commercially sensitive information, how does that apply to university research? Research is a competitive business, where the challenge is always to publish first. If your findings are already in the public domain, it becomes quite difficult to get a journal to take your article. Your standing in the research excellence framework will be affected. Your ability to secure future funds, grants and contracts may be compromised. Your reputation, and that of your institution, will be hit. Can the Minister explain what protections exist to prevent a competitor academic requesting your research data as they emerge? Universities UK, which supports this amendment and has provided an extremely helpful briefing to which other speakers have referred, has given an example of exactly this situation, in which a researcher was subject to FOI requests from a former collaborator who was now at a different institution. Another example comes from Queen Mary, University of London, where a research team was subject to an FOI request while still conducting its analysis. The university believed that, "““releasing data at the individual-participant level would prejudice publication of future study papers … and could set a precedent that may affect our ability to attract research funding and participants in the future””." Releasing data before the process of validation and analysis is complete also carries the risk that misleading information will get into the public domain. We know that this is a particular concern in medicine, where misleading information can have serious consequences for public health. The peer-review system in the UK is one of the major strengths of our research base because it ensures that, before findings are published, they are checked by experts. This helps to ensure that poorly designed and executed research with dubious findings does not enter the public domain. As the noble Baroness, Lady Brinton, mentioned, the Environmental Information Regulations include a protection for, "““material which is still in the course of completion, to unfinished documents or to incomplete data””." Why cannot FOI have something similar? We all want universities to do more to work effectively with business. Indeed, the Minister of State for Universities made an announcement about this only last week. The fact that university research can be subject to FOI causes difficulties in working with commercial research partners. Negotiations can often be long and difficult. Businesses will look at the recent cases where research findings have been requested by companies with a commercial interest in the data and wonder—quite legitimately, in my view—whether they would not be better off doing research with non-university research bodies that do not carry that responsibility. I, too, want to mention that in Scotland there is now a pre-publication exemption—on which the proposal in the amendment is modelled—which has been used to deal with exactly this point. Let me quote an example from one Scottish university, which received an FOI request for the annual report written for the funder of some early-stage research. There was no commercial value in the findings to date, but the report described avenues that could, with further investigation, yield commercially valuable results. Not surprisingly, the university wanted to use this information to apply for further funding, but that would have been compromised by releasing the report to potential competitors. The request was refused using the Scottish pre-publication exemption. Will the Minister tell the Committee whether he believes that it is right that researchers in Scotland and, as the noble Baroness, Lady Brinton, has said, in Ireland and the United States should have this protection that our universities do not have? I note that Universities UK is not alone in calling for this House to scrutinise the way in which this Bill relates to university research. The Wellcome Trust, the Association of Medical Research Charities and the Ethical Medicines Industry Group have all written to noble Lords in relation to this, especially in support of the amendments tabled by the noble Baroness, Lady O’Neill. I urge the Minister to consider whether he can accommodate these concerns by accepting this amendment. I do not believe that it will do any harm. It is clearly limited in its scope and it could do a great deal of good.